[Federal Register Volume 75, Number 166 (Friday, August 27, 2010)]
[Notices]
[Pages 52751-52752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-21351]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Global Health Affairs; Trans-Atlantic Task Force on
Antimicrobial Resistance (TATFAR)
AGENCY: Office of Global Health Affairs, HHS.
ACTION: Notice of public meeting and request for comments.
-----------------------------------------------------------------------
SUMMARY: The Office of Global Health Affairs is seeking comments and
[[Page 52752]]
suggestions from the public on the activities of the Trans-Atlantic
Taskforce on Antimicrobial Resistance (TATFAR).
DATES: A public meeting will be held in Bethesda, MD, on Friday,
October 1, 2010 from 1:30 to approximately 4:30 p.m. Persons wishing to
participate, including those who wish to make an oral presentation,
must register in advance and provide a copy of their presentation by
noon Friday, September 24, 2010.
Deadline for Registration for all Attendees: All Other Attendees
must register by noon, Friday, September 24, 2010.
Deadline for Requests for Special Accommodation: Requests for
special accommodation should be submitted by noon, Friday, September
17, 2010.
ADDRESSES: Meeting Location: The public meeting will be held on the
Campus of the National Institutes of Health, 9000 Rockville Pike,
Building 31, Wing C, Room 6, Bethesda, MD 20892.
Submission of Written Comments: Written comments can be e-mailed to
[email protected] or sent via regular mail to Elana Clarke, Office of
Global Health Affairs, Switzer Building Room 2319, 330 C Street, SW.,
Washington, DC 20201.
Registration and Special Accommodations: Individuals wishing to
participate or who need special accommodations or both must register by
contacting Elana Clarke at [email protected]. See Registration To
Attend and/or Participate in the Public Hearing for instructions on how
to submit electronic notices of participation.
FOR FURTHER INFORMATION CONTACT: Elana Clarke at [email protected]
or 202 260-0443.
Registration To Attend and/or Participate in the Public Meeting: To
ensure there is sufficient room we ask that you pre-register. If you
wish to make an oral presentation during the open public comment period
of the hearing, state your intention to present on your registration
submission. To register, please send an electronic mail message to
[email protected] by the deadline listed under DATES. Your e-mail
should include your name and e-mail address.
Please submit a written statement at the time of registration,
identifying each focus area you wish to address and the approximate
time requested to make your presentation. Organizations should provide
this information as well as the names and e-mail addresses of all
participants. Registered individuals will be notified of the
approximate time scheduled for their presentation prior to the meeting.
Depending on the number of presentations, HHS may need to limit the
time allotted for presentations.
SUPPLEMENTARY INFORMATION:
1. Background
On November 3, 2009, the United States and the European Union (EU)
agreed to establish a task force to focus ``on urgent antimicrobial
resistance issues focused on appropriate therapeutic use of
antimicrobial drugs in the medical and veterinary communities,
prevention of both healthcare- and community-associated drug-resistant
infections, and strategies for improving the pipeline of new
antimicrobial drugs, which could be better addressed by intensified
cooperation.'' (2009 EU-U.S. Summit Declaration).
The TATFAR is made up of government representatives from the U.S.
Department of Health and Human Services for the United States and from
the European Commission, European Union agencies, and representatives
of three EU member states for the EU. Information about the TATFAR is
available at: http://ecdc.europa.eu/en/activities/diseaseprogrammes/TATFAR/Pages/index.aspx.
2. Public Comment and Meeting
The public meeting process provides an opportunity for the public
to become aware of the activities of the TATFAR to date. In addition,
OGHA invites written comments and/or oral presentations of interested
persons on the three focus areas of the TATFAR as defined in the 2009
EU/US Summit Declaration:
Appropriate therapeutic use of antimicrobial drugs in the
medical and veterinary communities,
Prevention of both healthcare- and community-associated
drug-resistant infections, and
Strategies for improving the pipeline of new antimicrobial
drugs.
Comments should identify specific antimicrobial resistance-related
activities in these three areas where intensified cooperation between
the United States and the European Union could have the most impact,
keeping in mind that the work of the TATFAR will be carried out using
currently available resources. In particular, input is sought on
activities that can be undertaken in the near-term, with a reasonable
possibility of completion over the next 12-15 months.
Written comments submitted by e-mail should use the following
subject line ``TATFAR Comments.'' Comments and any documentation may be
submitted as Adobe PDF, MSWord or Text (.txt) files. Written comments
submitted by regular mail should clearly identify ``TATFAR Comments''
as the subject.
3. Building and Security Guidelines
The meeting is being held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, please take account of the need to clear security. All
visitors must enter through the NIH Gateway Center and must present
government-issued photo identification. All persons entering the
building must pass through a metal detector. All items brought to HHS
are subject to inspection. For more information on NIH security
requirements for visitors, please go to: http://www.nih.gov/about/visitorsecurity.htm.
Signed: August 23, 2010.
Nils Daulaire,
Director, Office of Global Health Affairs.
[FR Doc. 2010-21351 Filed 8-26-10; 8:45 am]
BILLING CODE 4150-38-P